Kane Biotech Stock Market Value
| KNBIF Stock | USD 0.03 0.0004 1.38% |
| Symbol | Kane |
Kane Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kane Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kane Biotech.
| 12/18/2025 |
| 01/17/2026 |
If you would invest 0.00 in Kane Biotech on December 18, 2025 and sell it all today you would earn a total of 0.00 from holding Kane Biotech or generate 0.0% return on investment in Kane Biotech over 30 days. Kane Biotech is related to or competes with Biovaxys Technology. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies ... More
Kane Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kane Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kane Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0023 | |||
| Maximum Drawdown | 27.72 | |||
| Value At Risk | (4.14) | |||
| Potential Upside | 7.06 |
Kane Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kane Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kane Biotech's standard deviation. In reality, there are many statistical measures that can use Kane Biotech historical prices to predict the future Kane Biotech's volatility.| Risk Adjusted Performance | 0.0239 | |||
| Jensen Alpha | 0.0095 | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | 0.0997 |
Kane Biotech Backtested Returns
At this point, Kane Biotech is out of control. Kane Biotech has Sharpe Ratio of 0.0224, which conveys that the firm had a 0.0224 % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Kane Biotech, which you can use to evaluate the volatility of the firm. Please verify Kane Biotech's Risk Adjusted Performance of 0.0239, standard deviation of 5.06, and Mean Deviation of 1.76 to check out if the risk estimate we provide is consistent with the expected return of 0.12%. Kane Biotech has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.02, which conveys a somewhat significant risk relative to the market. Kane Biotech returns are very sensitive to returns on the market. As the market goes up or down, Kane Biotech is expected to follow. Kane Biotech right now secures a risk of 5.14%. Please verify Kane Biotech maximum drawdown and the relationship between the kurtosis and price action indicator , to decide if Kane Biotech will be following its current price movements.
Auto-correlation | 0.00 |
No correlation between past and present
Kane Biotech has no correlation between past and present. Overlapping area represents the amount of predictability between Kane Biotech time series from 18th of December 2025 to 2nd of January 2026 and 2nd of January 2026 to 17th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kane Biotech price movement. The serial correlation of 0.0 indicates that just 0.0% of current Kane Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Kane Biotech lagged returns against current returns
Autocorrelation, which is Kane Biotech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kane Biotech's pink sheet expected returns. We can calculate the autocorrelation of Kane Biotech returns to help us make a trade decision. For example, suppose you find that Kane Biotech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kane Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kane Biotech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kane Biotech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kane Biotech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Kane Biotech Lagged Returns
When evaluating Kane Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kane Biotech pink sheet have on its future price. Kane Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kane Biotech autocorrelation shows the relationship between Kane Biotech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Kane Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Kane Pink Sheet
Kane Biotech financial ratios help investors to determine whether Kane Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kane with respect to the benefits of owning Kane Biotech security.